Generalizations in Clinical Trials—Do Generics Help Or Harm?

Generalizations in medical research can be informative, but also misleading. Building on recent work in the philosophy of science and ethics of communication, I offer a novel analysis of common generalizations in clinical trials as generics in natural language. Generics, which express generalization...

Descripción completa

Guardado en:  
Detalles Bibliográficos
Autor principal: Chin-Yee, Benjamin (Autor)
Tipo de documento: Electrónico Artículo
Lenguaje:Inglés
Verificar disponibilidad: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
Publicado: 2023
En: Kennedy Institute of Ethics journal
Año: 2023, Volumen: 33, Número: 4, Páginas: 359-400
Acceso en línea: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002c 4500
001 1917344430
003 DE-627
005 20250522204246.0
007 cr uuu---uuuuu
008 250217s2023 xx |||||o 00| ||eng c
024 7 |a 10.1353/ken.2023.a931051  |2 doi 
035 |a (DE-627)1917344430 
035 |a (DE-599)KXP1917344430 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Chin-Yee, Benjamin  |e VerfasserIn  |4 aut 
245 1 0 |a Generalizations in Clinical Trials—Do Generics Help Or Harm? 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Generalizations in medical research can be informative, but also misleading. Building on recent work in the philosophy of science and ethics of communication, I offer a novel analysis of common generalizations in clinical trials as generics in natural language. Generics, which express generalizations without terms of quantification, have attracted considerable attention from philosophers, psychologists, and linguists. My analysis draws on probabilistic and contextual features of generics to diagnose how these generalizations function and malfunction across communicative contexts in medicine. Given a high risk of misinterpretation ("slippage"), I recommend avoidance of generic claims about medical interventions in public contexts, exemplified by clinical trials and medical research more generally. Generics should only be used with vigilance in private contexts, exemplified by the physician-patient encounter. My analysis provides tools to support vigilance when communicating with generics, suggests new norms for public science communication, and raises deeper questions in the ethics of clinical communication. 
601 |a General 
773 0 8 |i Enthalten in  |a Kennedy Institute of Ethics  |t Kennedy Institute of Ethics journal  |d Baltimore, Md. : Johns Hopkins Univ. Press, 1991  |g 33(2023), 4, Seite 359-400  |h Online-Ressource  |w (DE-627)320481840  |w (DE-600)2009887-X  |w (DE-576)266818668  |x 1086-3249  |7 nnas 
773 1 8 |g volume:33  |g year:2023  |g number:4  |g pages:359-400 
856 4 0 |u https://doi.org/10.1353/ken.2023.a931051  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://muse.jhu.edu/pub/1/article/931051  |x Verlag  |z lizenzpflichtig  |3 Volltext 
889 |w (DE-627)1926312856 
912 |a NOMM 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4664788436 
LOK |0 003 DE-627 
LOK |0 004 1917344430 
LOK |0 005 20250522130311 
LOK |0 008 250217||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2025-05-21#D18406490D52B6C13DA34C6CEBF03EBBC2947ECC 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo  |a ixrk  |a zota 
OAS |a 1  |b inherited from superior work 
ORI |a TA-MARC-ixtheoa001.raw